This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: Between-subjects designs in which participants are assigned to treatment conditions by means other ... (Read 19 times)

newyorker26

  • Hero Member
  • *****
  • Posts: 536
on: Jun 20, 2018
Between-subjects designs in which participants are assigned to treatment conditions by means other than randomization are referred to as
 
  a. cross-lagged designs.
  b. longitudinal designs.
  c. nonequivalent-groups designs.
  d. single-case experimental designs.

Question 2

Which of the following is NOT a reason given for incorporating random assignment into one's research design?
 
  a. Random assignment permits the use of certain statistical tests.
   b. Random assignment prevents possible biases in determining which treatment a subject
   receives.
   c. Random assignment increases the reliability and validity of one's experimental design.
   d. Random assignment distributes the characteristics of the sampling units over all
   experimental conditions.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

gstein359

  • Sr. Member
  • ****
  • Posts: 293
Reply #1 on: Jun 20, 2018
Answer to Question 1

c

Answer to Question 2

c


newyorker26

  • Member
  • Posts: 536
Reply 2 on: Jun 20, 2018
:D TYSM

Mochi

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Gracias!

« previous next »
 

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

The black-capped chickadee is a permanent resident in biomes with harsh winter conditions. The black-capped chickadee is a permanent resident in biomes with harsh winter conditions.
Buprenorphine as a Treatment for Opiate Addiction Buprenorphine as a Treatment for Opiate Addiction
In the summer of 1793, a yellow fever epidemic struck Philadelphia, killing nearly 4,000. Tens of th In the summer of 1793, a yellow fever epidemic struck Philadelphia, killing nearly 4,000. Tens of th
Immediate Treatment of an MI Immediate Treatment of an MI
Agents Used in the Treatment of Diabetes Mellitus Agents Used in the Treatment of Diabetes Mellitus
Phantom Limb Treatment Phantom Limb Treatment
Video: Michaelis–Menten equation & Kinetic parameters

For a complete list of videos, visit our video library